Skip to main content

Table 1 Study characteristics

From: Nocturia in patients with cognitive dysfunction: a systematic review of the literature

Study

Population

Nocturia Assessment

Cognitive dysfunction Assessment

Dutoglu et al. (2019) [17]

858 outpatients admitted to a

geriatric center

Female: 100%

Mean (sd) age: 74.1 (8.2) years

“Generally, during the past

30 days, how many times do you usually urinate after you have gone to sleep at night until the time you got up in the morning?”

Cut-off: 1, 2, 3, 4 or more

Prevalence: 19.0, 24.2, 18.4, and 24.1% respectively

MMSE and Dementia diagnosed using the DSM V

Mean (sd) MMSE score: 24.7 (4.9), 25.0 (4.2), 24.9 (3.7), 24.2 (4.4), 23.9 (4.9) in patients with 0, 1, 2, 3 or ≥ 4 nocturia episodes respectively

Prevalence (dementia): 4.4%

Jung et al. (2017) [11]

376 patients with probable Alzheimer’s disease

Female: 51.1%

Age range: 56–92 years

OABSS

Mean (sd) number of nocturia episodes: 1.2 (0.8), 1.2 (0.9) and 1.6 (1.0) in patients with OABSS ≤5, 6–11 or ≥ 12 respectively

Prevalence: NR

MMSE and CDR scale

Mean (sd) MMSE score: 14.4 (7.6) in patients with OAB

Mean (sd) CDR score: 2.3 (0.9) in patients with OAB

Zhang et al. (2016) [18]

454 patients with Parkinson’s disease

Female: 42.7%

Mean (sd) age: 61.5 (10.9) years

NMSS

Mean (sd) NMSS score for nocturia: 2.4 (3.3)

Cut-off: NR

Prevalence: 47.2%

MoCA

Mean (sd) MoCA score: 23.7 (4.5)

Prevalence (MoCA ≤25): 58.1%

Scullin et al. (2013) [19]

143 patients with Parkinson’s disease

Female: 35%

Mean (sd) age: 64.7 (9.0) years

“When you awaken during the night, how often do you urinate?” on sleep questionnaire drawn from existing studies; Nocturia frequency evaluated on 4-point Likert scale (1 = “never,” 4 = “very often”)

Prevalence: NR

Impulsivity determined by at least 1 “yes” to the Minnesota Impulse Disorder Interview (MIDI) questions

Prevalence: 26.6%

Vaughan et al. (2013) [20]

63 patients with Parkinson’s disease

Female: 35%

Mean (sd) age: 63 (9.7) years

IPSS

Cut-off: ≥2 voids/nights

Prevalence: 61%

MMSE

Mean (sd) MMSE score: 28.6 (1.5) in patients without nocturia and 28.5 (1.9) in patients without

Prevalence: NR

Galizia et al. (2012) [21]

1288 community-dwelling individuals

Female: 57%

Mean (sd) age: 74.2 (6.3) years

History taking

Cut-off: ≥2 voids/nights

Prevalence: 45.8%

MMSE

Mean (sd) MMSE score: 25.3 (4.8)

Prevalence: NR

Lee et al. (2012) [22]

299 community-dwelling men

Mean (sd) age: 71.2 (5.0) years

History taking

Cut-off: ≥2 voids/nights

Prevalence: 56.0%

MMSE

Mean (sd) MMSE score: 25.6 (3.4)

Prevalence: NR

Burgio et al. (2010) [23]

1000 Medicare beneficiaries

Female: 50%

Mean (sd) age: 73.8 (NR) years

History taking

Cut-off: ≥2 voids/nights

Prevalence: 58.5%

MMSE

Mean (sd) MMSE score: 25 (4.9)

Prevalence (MMSE < 24): 29.8%

  1. BPH Benign prostatic hypertrophy, CI Confidence interval, CDR Clinical Dementia Rating; DSM Diagnostic and Statistical Manual of Mental Disorders, HAMA Hamilton Anxiety Rating Scale, HAMD Hamilton Depression Rating Scale, IPSS International Prostate Symptom Score, MoCA Montreal Cognitive Assessment, MMSE Mini-Mental State Examination, NMSS Non-Motor Symptom Scale, NR Not reported, OABSS Overactive Bladder Symptom Score, OR Odds ratio, r Correlation coefficient, sd Standard deviation, UPDRS Unified Parkinson’s Disease Rating Scale